4/A: InspireMD Director Amends Share Purchase Details

InspireMD Director Paul Stuka amended a Form 4 to correct the number of common shares purchased on December 9, 2025, at a weighted average price of $1.81.

Summary

• An amendment to Form 4 was filed, originally submitted on December 11, 2025.
• The purpose of this amendment is solely to correct the number of shares reported as acquired in Table I, Column 4.
• The number of shares beneficially owned following the reported transaction (Column 5) was correct as originally filed.
• Director Paul Stuka purchased 2,710 shares of InspireMD, Inc. Common Stock.
• The transaction occurred on December 9, 2025.
• The weighted average purchase price was $1.81 per share, with transactions ranging from $1.80 to $1.81.
• Following this transaction, Paul Stuka directly owns 391,628 shares of InspireMD, Inc.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director increased their stake, indicating confidence, although the transaction size is relatively small. The amendment itself is administrative.

Positives

• A director increased their direct beneficial ownership in the company by purchasing shares, which can signal confidence in the company's future.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider purchases, such as this one by a director, often reflect management's belief in the company's value and future prospects. While the transaction size is relatively small compared to total holdings, it generally indicates a positive sentiment from an informed individual within the company.

Related Party Transactions

• Director Paul Stuka purchased 2,710 shares of InspireMD, Inc. common stock on December 9, 2025, at a weighted average price of $1.81 per share.

Stakeholder Impact

• Shareholders may interpret the director's purchase as a positive sign of confidence in the company's performance and future value.

Key Dates

Keywords

InspireMD, NSPR, Form 4, Insider Transaction, Director Purchase, Beneficial Ownership, Common Stock